Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 15, 2022
- Accepted December 5, 2023
- Published online December 19, 2023.
Article Versions
- You are currently viewing a previous version of this article (December 19, 2023 - 03:26).
- View the most recent version of this article
Copyright & Usage
Copyright © 2023, Parenteral Drug Association
Author Information
- Candice Johnson1 (candice.johnson@instem.com),
- Douglas Kiehl2 (kiehl_douglas_e@lilly.com),
- Piet Christiaens3 (pchristiaens@nelsonlabs.com),
- Ferran Sancho Jodar4 (fsancho@zymvol.com),
- Ruud Cuyvers4 (rcuyvers@nelsonlabs.com),
- Arianna Bassan5 (arianna.bassan@innovatune.com),
- Lisa Beilke6 (lisa@toxsolutionsinc.com),
- Joel P Bercu7 (joel.bercu@gilead.com),
- Thomas Costelloe8 (tcostelloe@imihgom.com),
- Kevin P Cross1 (kevin.cross@instem.com),
- Andrew Feilden9 (andrew.feilden@bicycletx.com),
- Ron Filler10 (ron.filler@drugdevelopmentconsultants.com),
- Maria Fátima Lucas4 (flucas@zymvol.com),
- Melisa J Masuda-Herrera7 (melisa.masuda-herrera@gilead.com),
- Mona Moghimi8 (mmoghimi@imihgom.com),
- Nick Morley11 (nick.morley@element.com),
- Diane Paskiet12 (diane.paskiet@westpharma.com),
- Manuela Pavan5 (manuela.pavan@innovatune.com),
- Julia Pletz13 (jpletz@exponent.com),
- M. Vijayaraj Reddy14 (vijay.reddy@merck.com),
- Christopher J Waine15 (chris.waine@bibratoxadvice.co.uk) and
- Glenn J Myatt1,16 (glenn.myatt@instem.com)
- 1 Instem;
- 2 Eli Lilly and Company;
- 3 Nelson Labs;
- 4 Zymvol Biomodeling;
- 5 Innovatune;
- 6 Toxicology Solutions, Inc.;
- 7 Gilead Sciences;
- 8 IMIHGOM B.V.;
- 9 BicycleTx Ltd;
- 10 Drug Development Consultants, LLC;
- 11 Element Materials Technology;
- 12 West Pharmaceutical Services;
- 13 Exponent International Ltd.;
- 14 Merck & Co., Inc.;
- 15 Bibra Toxicology Advice and Consulting
- ↵* Corresponding author; email: glenn.myatt@instem.com
